UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040724
Receipt number R000046488
Scientific Title Screening of interstitial pneumonias by quantification of chest X-ray
Date of disclosure of the study information 2020/06/11
Last modified on 2022/07/20 11:58:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Screening of interstitial pneumonias by quantification of chest X-ray

Acronym

IP screening by chest X-ray

Scientific Title

Screening of interstitial pneumonias by quantification of chest X-ray

Scientific Title:Acronym

IP screening by chest X-ray

Region

Japan


Condition

Condition

Interstitial pneumonia

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To develop the findings of chest X-ray for the screening of interstitial pneumonias.

Basic objectives2

Others

Basic objectives -Others

Development of measurements

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Structural changes in chest X-ray that can evaluate the volume loss of the lungs

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients with interstitial pneumonias who underwent chest X-ray, chest CT and spirometry within 4 weeks
2) Control patients who do not have interstitial pneumonias or any pulmonary diseases and underwent chest X-ray, chest CT and spirometry within 4 weeks
3) Clinically stable patients who do not have a worsening of diseases.

Key exclusion criteria

1) Patients who lacks any of chest X-ray, chest CT and spirometry
2) chest X-ray, chest CT and spirometry were underwent over 4 weeks.
3) Clinically unstable patients who have worsening of diseases within 4 weeks.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Takafumi
Middle name
Last name Suda

Organization

Hamamatsu University School of Medicine

Division name

Department of Internal Medicine, Second Division

Zip code

4313192

Address

1-20-1 Handayama, Hamamatsu, Shizuoka, Japan

TEL

0534352263

Email

suda@hama-med.ac.jp


Public contact

Name of contact person

1st name Masato
Middle name
Last name Karayama

Organization

Hamamatsu University School of Medicine

Division name

Department of Chemotherapy

Zip code

4313192

Address

1-20-1 Handayama, Hamamatsu, Shizuoka, Japan

TEL

0534352419

Homepage URL


Email

karayama@hama-med.ac.jp


Sponsor or person

Institute

Department of Internal Medicine, Second Division, Hamamatsu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Internal Medicine, Second Division, Hamamatsu University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Clinical Trial

Address

1-20-1 Handayama, Hamamatsu, Shizuoka, Japan

Tel

0534352680

Email

rinri@hama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 06 Month 11 Day

Date of IRB

2020 Year 03 Month 26 Day

Anticipated trial start date

2020 Year 06 Month 30 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective observational study


Management information

Registered date

2020 Year 06 Month 11 Day

Last modified on

2022 Year 07 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046488


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name